Brolucizumab vs. Aflibercept for Retinal Angiomatous Proliferation
Clinical trial NCT04698850 · WITHDRAWN
Trial details
- NCT number
- NCT04698850
- Sponsor
- Faculty Hospital Kralovske Vinohrady
- Status
- WITHDRAWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-04
- Primary completion
- 2023-01-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.